A phase II study of cabozantinib in patients (pts) with relapsed or refractory metastatic urothelial carcinoma (mUC).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Andrea B. Apolo, Howard L. Parnes, Deneise C Francis, Lisa M Cordes, Marilise Berninger, Elizabeth Lamping, Rene Costello, Jane B. Trepel, Maria J Merino, Les Folio, Maria Liza Lindenberg, William Douglas Figg, Seth M. Steinberg, John Joseph Wright, Ravi Amrit Madan, Yangmin M. Ning, James L. Gulley, Donald P. Bottaro, William L. Dahut, Piyush K. Agarwal
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4250018997